Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A1 | P46059 | 2/20 | 0.55 |
| ▸ | LTA4H | P09960 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | XIAP | P98170 | 1/20 | 0.51 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432780 | 1.00 | SLC15A1 (0.55) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL4850398 | 1.00 | SLC15A1 (0.55) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL29398213 | 0.98 | SLC15A1 (0.53) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| Urea SCHEMBL4473115 | 0.97 | SLC15A1 (0.52) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| Glutamic Acid SCHEMBL7243656 | 0.95 | SLC1A1 (0.53) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| Alanine SCHEMBL4410297 | 0.94 | SLC15A1 (0.52) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL8411886 | 0.94 | LTA4H (0.50) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| Glutamic Acid SCHEMBL28192477 | 0.92 | SLC1A1 (0.49) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL28389656 | 0.92 | SLC1A1 (0.49) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL13764234 | 0.91 | SLC15A1 (0.52) | SLC15A1LTA4HALDH1A1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1851 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695257-A1 | PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SALTS THEREOF | Harman Finochem Limited (IN) | 2026-02-18 | — | — | EP | claimed |
| US-20260027218-A1 | STAR-SHAPED GRAFT COPOLYMERS | POLYPEPTIDE THERAPEUTIC SOLUTIONS S L (ES) | 2026-01-29 | — | — | US | claimed |
| EP-4674441-A1 | RARE EARTH NANO FLUORESCENCE-NUCLEAR MEDICINE TUMOR TOMOGRAPHY-THERAPY INTEGRATED PREPARATION, PREPARING METHOD THEREFOR, AND USE METHOD AND USE THEREOF | Zhongke Rare Earth Nanotechnology (Hebei) Co., Ltd (CN) | 2026-01-07 | — | — | EP | claimed |
| US-12487218-B2 | Polymer nanostructures, methods of making same, and uses thereof | CORNELL UNIVERSITY (US) | 2025-12-02 | — | — | US | claimed |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | claimed |
| CN-120136804-A | Glutamic acid-N-carboxyl-cyclic anhydride monomer containing ethyl nitrate group, polymer thereof and application of glutamic acid-N-carboxyl-cyclic anhydride monomer serving as nitric oxide donor | 武汉理工大学 | 2025-06-13 | — | — | CN | claimed |
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | WASHINGTON UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| EP-4532586-A1 | STAR-SHAPED GRAFT COPOLYMERS | Polypeptide Therapeutic Solutions, S.L. (ES) | 2025-04-09 | — | — | EP | claimed |
| CN-119681258-A | Hybrid gold nanoparticle and preparation method and application thereof | 嘉庚创新实验室 | 2025-03-25 | — | — | CN | claimed |
| CN-119605880-A | Processing technology of floating beam green tea | 浮梁县天祥茶号有限公司 | 2025-03-14 | — | — | CN | claimed |
| EP-0362031-B1 | COMPOUNDS ACTIVE AGAINST MALARIA OF THE TISSUES, AND PROCESS FOR THEIR PREPARATION | LA REGION WALLONNE (BE) | 1993-07-07 | — | — | EP | claimed |
| WO-1992018518-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1992-10-29 | — | — | WO | claimed |
| US-5007930-A | Coating a supplementation or replacement; dentistry, bone prosthetics | THE DOW CHEMICAL COMPANY (US) | 1991-04-16 | — | — | US | claimed |
| EP-0362031-A1 | Compounds active against malaria of the tissues, and process for their preparation | LA REGION WALLONNE (BE) | 1990-04-04 | — | — | EP | claimed |
| EP-0213996-B1 | RAMIFIED POLYMERS BASED ON LIPOPEPTIDES FORMING THERMOTROPIC AND LYOTROPIC LIQUID CRYSTALS, THEIR USE AND CORRESPONDING MONOMERS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1989-09-06 | — | — | EP | claimed |
| US-4842604-A | MOLDING AND IMPLANTING POROUS MATERIAL; POLYESTER OR AMINO ACID POLYMER | THE DOW CHEMICAL COMPANY (US) | 1989-06-27 | — | — | US | claimed |
| US-4698375-A | POLYGLYCOLIC ACID, LATIC ACID, HYDROXYBUTYRATE, ALPHA-AMINO ACID | THE DOW CHEMICAL COMPANY (US) | 1987-10-06 | — | — | US | claimed |
| US-4636526-A | Composites of unsintered calcium phosphates and synthetic biodegradable polymers useful as hard tissue prosthetics | THE DOW CHEMICAL COMPANY (US) | 1987-01-13 | — | — | US | claimed |
| US-4525495-A | CONTAINING AMINO ACID POLYMER | THE DOW CHEMICAL COMPANY (US) | 1985-06-25 | — | — | US | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171495-A1 | MUTLI-TARGETED SERINE PROTEASE INHIBITORS FOR TREATMENT OF CANCER AND VIRAL INFECTION | TMPRSS2, PRSS1, PRSS2 | SLC15A1 1329/4885LTA4H 2097/4885ALDH1A1 2588/4885 |
| US-20260027218-A1 | STAR-SHAPED GRAFT COPOLYMERS | RHOA, PCNA, HBZ | SLC15A1 2709/4885LTA4H 4148/4885ALDH1A1 4727/4885 |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | F11, F2, F12 | SLC15A1 4543/4885LTA4H 209/4885ALDH1A1 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.